FanYang_HealthEcon

Health economist @analysisgroup, previously @CHEyork @HealthEcon_MCR. Views my own.

[MrBeast @MrBeast]

I’m gonna give 10 random people that repost this and follow me $25,000 for fun (the $250,000 my X video made)

I’ll pick the winners in 72 hours

[The Centre for Health Economics @CHEyork]

We are pleased to publish the 2021 Annual Report for the Centre for Health Economics
https://t.co/TE1jKwhCTi

[FanYang_HealthEcon @FanYangHealthEc]

Using a survey plus an animated video to understand people’s views on health inequality. Our paper demonstrates the feasibility of this approach and estimates an inequality aversion parameter for Uganda @thanzilaonse @kennykatumba @CHEyork https://t.co/Y59DvKXp4Z

[EuroQol @EuroQol]

New book published today! An essential guide to value sets for EQ-5D-5L. Available via open access @SpringerHealth. #EQ5D https://t.co/wZuQwB3xRs
1/3

[EuroQol @EuroQol]

The aim of the 2nd EuroQol African Academy Meeting is to help build capacity in the field of HTA, measurement of health-related quality of life, and cost utility analysis with an emphasis on the role of patient reported outcome measures, particularly EQ-5D.

2/2

[Thanzi Programme @thanzilaonse]

The first EQ-5D-5L value set and user guide for Uganda have been published, offering a 'lite' protocol to support health economic evaluations and health technology assessment for healthcare decision making in Uganda and East Africa. Read more here: https://t.co/BlEYiVuY0a

[EuroQol @EuroQol]

A value set for the EQ-5D-5L for Uganda is now available, published Open Access in Pharmacoeconomics by Fan Yang, Kenneth Katumba and colleagues. #EQ5D @FanYangHealthEc @kennykatumba https://t.co/gImdt8uazR (1of2)

[Kenny Katumba @kennykatumba]

This work was a collaboration between @MRC_Uganda, @CHEyork, @IDIMakerere , @LSHTM, and was supported by @thanzilaonse and @EuroQol. Many thanks to my co PI @FanYangHealthEc for great teamwork and co-lead.

[FanYang_HealthEcon @FanYangHealthEc]

Using a smaller sample to develop the EQ-5D-5L value set in resource-constrained settings, our study suggests its feasibility and developed the value set for Uganda.
Great team work! @thanzilaonse @EuroQol
https://t.co/Ub2w6Wd1HI

[Laura Bojke @bojke_laura]

Come to work with us @CHEyork
Research Fellow in Health Economics at University of York https://t.co/oSEjhJGDbC

[FanYang_HealthEcon @FanYangHealthEc]

If you are interested to conduct economic evaluations incorporating impact on health inequality, please come to join this #SMDM21 short course!

[The Centre for Health Economics @CHEyork]

In this SMDM short course, we will address that gap by teaching participants how to quantify health inequality impacts in economic evaluation of health policies and interventions.

https://t.co/CRYDfsMDL8

[The Centre for Health Economics @CHEyork]

Cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of the GeDiForCE model in Australia. @FanYangHealthEc https://t.co/JCBhfxS0iP

[The Centre for Health Economics @CHEyork]

We are pleased to publish the 2020 Annual Report for CHE. Details of our research activities over 2020, events and collaborations, training and workshops, outputs and presentations, as well as profiles of our new staff and students. https://t.co/x87Ty8cPqO

[The Centre for Health Economics @CHEyork]

CHEs latest research paper 184.
Comparing smoking cessation to screening and brief intervention for alcohol... @FanYangHealthEc @AnaDuarte_York @MJSculpher @simonwalker48
https://t.co/rQvbdb7ZG0

[The Centre for Health Economics @CHEyork]

Learn about health economics & cost-effectiveness from the experts at York's Centre for Health Economics @MJSculpher, @amancayork, Mike Drummond, @RitaINdeFaria with the 2021 York Online Workshops in Health Economic Evaluation
Bookings open now https://t.co/otXLDVNwv4

[Patricia Synnott @PSynnott29]

New paper from @FanYangHealthEc & colleagues used @TuftsCEVR Global Health CEA Registry to examine degree to which inequalities are considered in economic evaluations of health interventions in LMICs https://t.co/doXtBlTg6m

[FanYang_HealthEcon @FanYangHealthEc]

Using an illustrative example, we demonstrate how the uncertainty analysis could be conducted in distributional cost-effectiveness analysis (DCEA) to inform policy recommendations. Read more in our paper in @MedDecMak

https://t.co/5p3xUj2DmH

[FanYang_HealthEcon @FanYangHealthEc]

Health-related quality of life of a conflict-affected population in Colombia
https://t.co/OWLSCfa87c

#EQ5D to be a valid instrument for HRQoL measurement in a conflict-affected population.
Likely POSITIVE impact of the Colombian peace accord

[The Centre for Health Economics @CHEyork]

Considering health inequality impact in decision making: What does it mean for policy makers? CHE's latest Policy Briefing https://t.co/unnb6vqQ33

[Colin Angus @VictimOfMaths]

We've got a new paper out today in @MedDecMak, led by @FanYangHealthEc on the incorporation of inequality considerations in cost-effectiveness analysis.

tl;dr if you want to do an equity-informative CEA, you have to do it properly. There are no shortcuts.
https://t.co/DJAJHYZqCC